2022
Annual Results Presentation
March 2023
Chapter I Annual Performance Review
Chapter II Macro Economy and Industry Policies
Chapter III Business Highlights and Future Strategies
Annual Performance
Review
The economies of scale grew steadily and the business structure has been continuously optimized
Unit: RMB million
Profitability grew effectively and operating efficiency accelerated to improve
Unit: RMB million
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Sinopharm Group Co. Ltd. published this content on 25 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 March 2023 10:27:02 UTC.